Shares of Surgery Partners, Inc. (NASDAQ:SGRY – Get Free Report) have been given an average rating of “Moderate Buy” by the eight ratings firms that are covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $40.71.
SGRY has been the topic of several research reports. Royal Bank of Canada reissued an “outperform” rating and set a $49.00 price objective on shares of Surgery Partners in a research note on Wednesday, August 7th. KeyCorp initiated coverage on shares of Surgery Partners in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. Cantor Fitzgerald reissued an “overweight” rating and set a $43.00 price objective on shares of Surgery Partners in a research note on Friday, October 4th. StockNews.com downgraded shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, August 7th. Finally, Macquarie dropped their target price on shares of Surgery Partners from $35.00 to $34.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 13th.
Get Our Latest Research Report on Surgery Partners
Surgery Partners Price Performance
Surgery Partners (NASDAQ:SGRY – Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The company had revenue of $770.40 million for the quarter, compared to analysts’ expectations of $768.99 million. During the same quarter in the prior year, the firm earned $0.15 EPS. Surgery Partners’s quarterly revenue was up 14.3% compared to the same quarter last year. As a group, equities analysts predict that Surgery Partners will post 0.83 earnings per share for the current year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SGRY. Janus Henderson Group PLC lifted its position in Surgery Partners by 7,987.1% during the first quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company’s stock valued at $74,701,000 after purchasing an additional 2,473,282 shares during the period. Deerfield Management Company L.P. Series C increased its holdings in Surgery Partners by 47.7% during the second quarter. Deerfield Management Company L.P. Series C now owns 4,707,287 shares of the company’s stock valued at $111,986,000 after buying an additional 1,520,484 shares during the last quarter. King Street Capital Management L.P. purchased a new stake in shares of Surgery Partners in the third quarter worth $46,748,000. Point72 Asset Management L.P. purchased a new stake in shares of Surgery Partners in the second quarter worth $29,288,000. Finally, Victory Capital Management Inc. increased its stake in shares of Surgery Partners by 140.4% in the third quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock worth $42,892,000 after purchasing an additional 777,038 shares in the last quarter.
Surgery Partners Company Profile
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Further Reading
- Five stocks we like better than Surgery Partners
- What is the Shanghai Stock Exchange Composite Index?
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- What is MarketRankā¢? How to Use it
- Applied Materials Market Capitulates: Now is the Time to Buy
- What Makes a Stock a Good Dividend Stock?
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.